| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 01:03:02 UTC |
|---|
| Update Date | 2021-09-26 22:57:50 UTC |
|---|
| HMDB ID | HMDB0247897 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | Tyr-Leu-Tyr-Glu-Ile-Ala-Arg |
|---|
| Description | Tyr-Leu-Tyr-Glu-Ile-Ala-Arg belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another. Based on a literature review very few articles have been published on Tyr-Leu-Tyr-Glu-Ile-Ala-Arg. This compound has been identified in human blood as reported by (PMID: 31557052 ). Tyr-leu-tyr-glu-ile-ala-arg is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Tyr-Leu-Tyr-Glu-Ile-Ala-Arg is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CCC(C)C(NC(=O)C(CCC(O)=O)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CC(C)C)NC(=O)C(N)CC1=CC=C(O)C=C1)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(O)=O InChI=1S/C44H66N10O12/c1-6-24(4)36(42(64)49-25(5)37(59)51-32(43(65)66)8-7-19-48-44(46)47)54-39(61)31(17-18-35(57)58)50-41(63)34(22-27-11-15-29(56)16-12-27)53-40(62)33(20-23(2)3)52-38(60)30(45)21-26-9-13-28(55)14-10-26/h9-16,23-25,30-34,36,55-56H,6-8,17-22,45H2,1-5H3,(H,49,64)(H,50,63)(H,51,59)(H,52,60)(H,53,62)(H,54,61)(H,57,58)(H,65,66)(H4,46,47,48) |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C44H66N10O12 |
|---|
| Average Molecular Weight | 927.07 |
|---|
| Monoisotopic Molecular Weight | 926.486167605 |
|---|
| IUPAC Name | 4-(2-{2-[2-amino-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido}-3-(4-hydroxyphenyl)propanamido)-4-[(1-{[1-({1-carboxy-4-[(diaminomethylidene)amino]butyl}carbamoyl)ethyl]carbamoyl}-2-methylbutyl)carbamoyl]butanoic acid |
|---|
| Traditional Name | 4-(2-{2-[2-amino-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido}-3-(4-hydroxyphenyl)propanamido)-4-[(1-{[1-({1-carboxy-4-[(diaminomethylidene)amino]butyl}carbamoyl)ethyl]carbamoyl}-2-methylbutyl)carbamoyl]butanoic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCC(C)C(NC(=O)C(CCC(O)=O)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CC(C)C)NC(=O)C(N)CC1=CC=C(O)C=C1)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C44H66N10O12/c1-6-24(4)36(42(64)49-25(5)37(59)51-32(43(65)66)8-7-19-48-44(46)47)54-39(61)31(17-18-35(57)58)50-41(63)34(22-27-11-15-29(56)16-12-27)53-40(62)33(20-23(2)3)52-38(60)30(45)21-26-9-13-28(55)14-10-26/h9-16,23-25,30-34,36,55-56H,6-8,17-22,45H2,1-5H3,(H,49,64)(H,50,63)(H,51,59)(H,52,60)(H,53,62)(H,54,61)(H,57,58)(H,65,66)(H4,46,47,48) |
|---|
| InChI Key | VSNQHTMELQVEOS-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Peptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha peptide
- Arginine or derivatives
- N-acyl-alpha-amino acid
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid or derivatives
- Amphetamine or derivatives
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Phenol
- Monocyclic benzene moiety
- Dicarboxylic acid or derivatives
- Benzenoid
- Amino acid or derivatives
- Amino acid
- Guanidine
- Carboximidic acid
- Carboximidic acid derivative
- Carboxylic acid
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Carboximidamide
- Organic oxide
- Organic oxygen compound
- Amine
- Organic nitrogen compound
- Carbonyl group
- Imine
- Primary aliphatic amine
- Hydrocarbon derivative
- Primary amine
- Organonitrogen compound
- Organooxygen compound
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 14.1269 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 6.75 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1840.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 135.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 202.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 158.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 133.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 441.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 449.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 1076.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 962.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 591.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1362.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 298.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 369.2 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 290.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 648.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 132.4 seconds | 40023050 |
Predicted Kovats Retention IndicesNot Available |
|---|
| MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tyr-Leu-Tyr-Glu-Ile-Ala-Arg 10V, Positive-QTOF | splash10-0kdi-0244158009-e8fed480da75e217cc17 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tyr-Leu-Tyr-Glu-Ile-Ala-Arg 20V, Positive-QTOF | splash10-03du-2910025000-6d6b68a50523be0c755d | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tyr-Leu-Tyr-Glu-Ile-Ala-Arg 40V, Positive-QTOF | splash10-08g3-3911002000-5169376614405ec4462f | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tyr-Leu-Tyr-Glu-Ile-Ala-Arg 10V, Negative-QTOF | splash10-0059-2100143349-4944b0d502afcd1f57f0 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tyr-Leu-Tyr-Glu-Ile-Ala-Arg 20V, Negative-QTOF | splash10-0pbi-3443519172-4713a7b55f718d5fb474 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tyr-Leu-Tyr-Glu-Ile-Ala-Arg 40V, Negative-QTOF | splash10-0006-7903303020-8bf462f7288e19d636f1 | 2021-10-12 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum |
|
|---|